10960sek
-1,1 %
Date:2026-01-30Time:18:00:00Latest report:Q3-2025List:Mid CapTicker:BIOG B
Market Cap:11 087 msekEnterprise Value:10 359 msekNet Sales:1 462 msekEarnings:315,9 msekEmployees:0ISIN:SE0017769995
Ratios
10-year key figure history for BioGaia turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for BioGaia with index and moving average MA50 and MA200.
Stockprice:109,60
MA50:104,51
MA200:103,11
Price/MA200:6,3 %
RSI (14):53,5
Price/MA50:4,9 %
Description
BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.